Jazz Pharmaceuticals (DE:J7Z)
FRANKFURT:J7Z
Holding DE:J7Z?
Track your performance easily

Jazz Pharmaceuticals (J7Z) Financial Statements

1 Followers

Jazz Pharmaceuticals Financial Overview

Jazz Pharmaceuticals's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Jazz Pharmaceuticals is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is €4.97. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.02B$ 901.98M$ 1.01B$ 972.14M$ 946.99M
Gross Profit$ 1.02B$ 901.98M$ 904.69M$ 1.07B$ 1.05B
EBIT$ 137.91M$ 92.54M-$ 99.52M$ 81.78M
EBITDA$ 300.95M$ 255.92M-$ 262.08M$ 241.36M
Net Income Common Stockholders$ 168.57M$ -14.62M$ 94.15M$ 146.82M$ 104.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.36B$ 1.44B$ 1.51B$ 1.34B$ 1.28B
Total Assets$ 11.36B$ 11.33B$ 11.39B$ 11.20B$ 11.26B
Total Debt$ 5.77B$ 5.77B$ 5.77B$ 5.78B$ 5.78B
Net Debt$ 4.42B$ 4.32B$ 4.27B$ 4.44B$ 4.50B
Total Liabilities$ 7.60B$ 7.63B$ 7.66B$ 7.71B$ 7.73B
Stockholders Equity$ 3.76B$ 3.70B$ 3.74B$ 3.49B$ 3.53B
Cash Flow-
Free Cash Flow$ 324.26M$ 260.32M-$ 302.90M$ 291.03M
Operating Cash Flow$ 331.35M$ 267.23M$ 167.34M$ 307.19M$ 296.76M
Investing Cash Flow$ -257.09M$ -271.90M$ 101.80M$ -174.30M$ -85.74M
Financing Cash Flow$ -161.09M$ -56.55M$ -100.31M$ -78.49M$ -96.67M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

Jazz Pharmaceuticals Debt to Assets

Jazz Pharmaceuticals Cash Flow

Jazz Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis